{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:03:50Z","timestamp":1792800230942,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31900441"],"award-info":[{"award-number":["31900441"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373097"],"award-info":[{"award-number":["82373097"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172565"],"award-info":[{"award-number":["82172565"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81502937"],"award-info":[{"award-number":["81502937"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2019MC026"],"award-info":[{"award-number":["ZR2019MC026"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023QH080"],"award-info":[{"award-number":["ZR2023QH080"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["WSR2023085"],"award-info":[{"award-number":["WSR2023085"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Funds of Shandong Traditional Chinese Medicine Science and Technology Development Project","award":["2019-0514"],"award-info":[{"award-number":["2019-0514"]}]},{"name":"Qilu Outstanding Young Talents in Health Project and Taishan Scholarship"},{"name":"Ministry of Education \"Chunhui\" plan international cooperation project","award":["HZKY20220459"],"award-info":[{"award-number":["HZKY20220459"]}]},{"name":"Research Foundation of Binzhou Medical University Hospital","award":["2022-01"],"award-info":[{"award-number":["2022-01"]}],"id":[{"id":"https:\/\/ror.org\/008w1vb37","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Research Foundation of Binzhou Medical University Hospital","award":["BY2022KJ64"],"award-info":[{"award-number":["BY2022KJ64"]}],"id":[{"id":"https:\/\/ror.org\/008w1vb37","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Research foundation of Johannes Kepler University","award":["2020-2026"],"award-info":[{"award-number":["2020-2026"]}]},{"name":"Tyle Private Foundation","award":["BERM16108001"],"award-info":[{"award-number":["BERM16108001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Biol Lett"],"DOI":"10.1186\/s11658-025-00808-5","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:10:09Z","timestamp":1762524609000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["lncRNA IGFL2-AS1 mediates NSCLC chemoresistance via YBX1-induced HSPA1A\/RAP1 activation"],"prefix":"10.1186","volume":"30","author":[{"given":"Hongliang","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxiu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuilan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingjie","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nailiang","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangling","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens A.","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"issue":"1","key":"808_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"7782","key":"808_CR2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","volume":"575","author":"N Vasan","year":"2019","unstructured":"Vasan N, Baselga J, Hyman DM. A view on drug resistance in cancer. Nature. 2019;575(7782):299\u2013309.","journal-title":"Nature"},{"issue":"11","key":"808_CR3","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41568-019-0196-7","volume":"19","author":"JH Bushweller","year":"2019","unstructured":"Bushweller JH. Targeting transcription factors in cancer\u2014from undruggable to reality. Nat Rev Cancer. 2019;19(11):611\u201324.","journal-title":"Nat Rev Cancer"},{"key":"808_CR4","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.semcancer.2022.08.001","volume":"86","author":"YW Li","year":"2022","unstructured":"Li YW, Azmi AS, Mohammad RM. Deregulated transcription factors and poor clinical outcomes in cancer patients. Semin Cancer Biol. 2022;86:122\u201334.","journal-title":"Semin Cancer Biol"},{"issue":"12","key":"808_CR5","doi-asserted-by":"publisher","first-page":"4308","DOI":"10.3390\/ijms21124308","volume":"21","author":"M Tolomeo","year":"2020","unstructured":"Tolomeo M, Grimaudo S. The, \u201cJanus\u201d role of C\/EBPs family members in cancer progression. Int J Mol Sci. 2020;21(12):4308.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"808_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12885-023-10543-9","volume":"23","author":"HC Long","year":"2023","unstructured":"Long HC, Li YY, Wang HJ, Guo BX, Song SY, Zhe XY, et al. C\/EBPbeta expression decreases in cervical cancer and leads to tumorigenesis. BMC Cancer. 2023;23(1):79.","journal-title":"BMC Cancer"},{"issue":"1","key":"808_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41523-021-00372-z","volume":"8","author":"BA Sterken","year":"2022","unstructured":"Sterken BA, Ackermann T, Muller C, Zuidhof HR, Kortman G, Hernandez-Segura A, et al. C\/EBPbeta isoform-specific regulation of migration and invasion in triple-negative breast cancer cells. NPJ Breast Cancer. 2022;8(1):11.","journal-title":"NPJ Breast Cancer"},{"issue":"3","key":"808_CR8","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.gendis.2015.05.001","volume":"2","author":"L Prabhu","year":"2015","unstructured":"Prabhu L, Hartley A-V, Martin M, Warsame F, Sun E, Lu T. Role of post-translational modification of the Y box binding protein 1 in human cancers. Genes Dis. 2015;2(3):240\u20136.","journal-title":"Genes Dis"},{"issue":"22","key":"808_CR9","doi-asserted-by":"publisher","first-page":"5589","DOI":"10.1158\/0008-5472.CAN-21-1606","volume":"81","author":"N Wajapeyee","year":"2021","unstructured":"Wajapeyee N, Gupta R. Epigenetic alterations and mechanisms that drive resistance to targeted cancer therapies. Cancer Res. 2021;81(22):5589\u201395.","journal-title":"Cancer Res"},{"issue":"12","key":"808_CR10","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1016\/j.molcel.2022.05.027","volume":"82","author":"AB Herman","year":"2022","unstructured":"Herman AB, Tsitsipatis D, Gorospe M. Integrated lncrna function upon genomic and epigenomic regulation. Mol Cell. 2022;82(12):2252\u201366.","journal-title":"Mol Cell"},{"issue":"1","key":"808_CR11","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12943-020-01162-0","volume":"19","author":"KS Liu","year":"2020","unstructured":"Liu KS, Gao L, Ma XS, Huang JJ, Chen J, Zeng LL, et al. Long non-coding RNAs regulate drug resistance in cancer. Mol Cancer. 2020;19(1):54.","journal-title":"Mol Cancer"},{"issue":"1","key":"808_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41392-022-00975-3","volume":"7","author":"BQ Chen","year":"2022","unstructured":"Chen BQ, Dragomir MP, Yang C, Li QQ, Horst D, Calin GA. Targeting non-coding RNAs to overcome cancer therapy resistance. Signal Transduct Target Ther. 2022;7(1):121.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"808_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12943-020-01171-z","volume":"19","author":"XY Zhang","year":"2020","unstructured":"Zhang XY, Xie K, Zhou HH, Wu YW, Li C, Liu YT, et al. Role of non-coding RNAs and RNA modifiers in cancer therapy resistance. Mol Cancer. 2020;19(1):47.","journal-title":"Mol Cancer"},{"issue":"16","key":"808_CR14","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1182\/blood.2023021991","volume":"144","author":"K Grillone","year":"2024","unstructured":"Grillone K, Ascrizzi S, Cremaschi P, Amato J, Poler\u00e0 N, Croci O, et al. An unbiased lncRNA dropout CRISPR-Cas9 screen reveals RP11-350G8.5 as a novel therapeutic target for multiple myeloma. Blood. 2024;144(16):1705\u201321.","journal-title":"Blood"},{"issue":"23","key":"808_CR15","doi-asserted-by":"publisher","first-page":"4637","DOI":"10.1038\/s41388-019-0747-0","volume":"38","author":"WM He","year":"2019","unstructured":"He WM, Liang BS, Wang CL, Li SW, Zhao Y, Huang Q, et al. MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer. Oncogene. 2019;38(23):4637\u201354.","journal-title":"Oncogene"},{"key":"808_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2022.01.031","volume":"531","author":"ZA Cheng","year":"2022","unstructured":"Cheng ZA, Lu CL, Wang H, Wang N, Cui SH, Yu CT, et al. Long noncoding RNA LHFPL3-AS2 suppresses metastasis of non-small cell lung cancer by interacting with SFPQ to regulate TXNIP expression. Cancer Lett. 2022;531:1\u201313.","journal-title":"Cancer Lett"},{"issue":"1","key":"808_CR17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41420-023-01442-w","volume":"9","author":"HL Dong","year":"2023","unstructured":"Dong HL, Zeng LL, Chen WW, Zhang Q, Wang F, Wu Y, et al. N6-methyladenine-mediated aberrant activation of the lncRNA SOX2OT-GLI1 loop promotes non-small-cell lung cancer stemness. Cell Death Discov. 2023;9(1):149.","journal-title":"Cell Death Discov"},{"issue":"18","key":"808_CR18","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/s41388-023-02883-4","volume":"43","author":"WW Chen","year":"2024","unstructured":"Chen WW, Wang F, Yu XY, Qi JJ, Dong HL, Cui BJ, et al. LncRNA MIR31HG fosters stemness malignant features of non-small cell lung cancer via H3K4me1- and H3K27Ace-mediated GLI2 expression. Oncogene. 2024;43(18):1328\u201340.","journal-title":"Oncogene"},{"issue":"1","key":"808_CR19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12943-021-01338-2","volume":"20","author":"P Khan","year":"2021","unstructured":"Khan P, Siddiqui JA, Lakshmanan I, Ganti AK, Salgia R, Jain M, et al. RNA-based therapies: a cog in the wheel of lung cancer defense. Mol Cancer. 2021;20(1):54.","journal-title":"Mol Cancer"},{"key":"808_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2022.100888","volume":"65","author":"B Parma","year":"2022","unstructured":"Parma B, Wurdak H, Ceppi P. Harnessing mitochondrial metabolism and drug resistance in non-small cell lung cancer and beyond by blocking heat-shock proteins. Drug Resist Updat. 2022;65:100888.","journal-title":"Drug Resist Updat"},{"issue":"5","key":"808_CR21","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.1002\/jcp.30132","volume":"236","author":"MA Vostakolaei","year":"2021","unstructured":"Vostakolaei MA, Hatami-Baroogh L, Babaei G, Molavi O, Kordi S, Abdolalizadeh J. Hsp70 in cancer: a double agent in the battle between survival and death. J Cell Physiol. 2021;236(5):3420\u201344.","journal-title":"J Cell Physiol"},{"issue":"1","key":"808_CR22","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12943-021-01419-2","volume":"20","author":"K Rindler","year":"2021","unstructured":"Rindler K, Jonak C, Alkon N, Thaler FM, Kurz H, Shaw LE, et al. Single-cell RNA sequencing reveals markers of disease progression in primary cutaneous T-cell lymphoma. Mol Cancer. 2021;20(1):124.","journal-title":"Mol Cancer"},{"issue":"13","key":"808_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111428","volume":"40","author":"M Oron","year":"2022","unstructured":"Oron M, Grochowski M, Jaiswar A, Legierska J, Jastrzebski K, Nowak-Niezgoda M, et al. The molecular network of the proteasome machinery inhibition response is orchestrated by HSP70, revealing vulnerabilities in cancer cells. Cell Rep. 2022;40(13):111428.","journal-title":"Cell Rep"},{"key":"808_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.636632","volume":"11","author":"NN Zhao","year":"2021","unstructured":"Zhao NN, Zhang JJ, Zhao LL, Fu XN, Zhao Q, Chao M, et al. Long noncoding RNA NONHSAT079852.2 contributes to GBM recurrence by functioning as a ceRNA for has-mir-10401-3p to facilitate HSPA1A upregulation. Front Oncol. 2021;11:636632.","journal-title":"Front Oncol"},{"issue":"7","key":"808_CR25","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1136\/gutjnl-2022-327853","volume":"72","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Xu YJ, Zheng C, Ye L, Jiang P, Malik S, et al. Acetyltransferase from Akkermansia muciniphila blunts colorectal tumourigenesis by reprogramming tumour microenvironment. Gut. 2023;72(7):1308\u201318.","journal-title":"Gut"},{"key":"808_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2022.100904","volume":"66","author":"JN Li","year":"2023","unstructured":"Li JN, Zhu LP, Kwok HF. Nanotechnology-based approaches overcome lung cancer drug resistance through diagnosis and treatment. Drug Resist Updat. 2023;66:100904.","journal-title":"Drug Resist Updat"},{"issue":"21","key":"808_CR27","doi-asserted-by":"publisher","first-page":"9597","DOI":"10.18632\/aging.102407","volume":"11","author":"G Cheng","year":"2019","unstructured":"Cheng G, Liu D, Liang HG, Yang HM, Chen K, Zhang XP. A cluster of long non-coding RNAs exhibit diagnostic and prognostic values in renal cell carcinoma. Aging. 2019;11(21):9597\u2013615.","journal-title":"Aging"},{"issue":"2","key":"808_CR28","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1002\/jcp.25997","volume":"233","author":"KM Tracy","year":"2018","unstructured":"Tracy KM, Tye CE, Page NA, Fritz AJ, Stein JL, Lian JB, et al. Selective expression of long non-coding RNAs in a breast cancer cell progression model. J Cell Physiol. 2018;233(2):1291\u20139.","journal-title":"J Cell Physiol"},{"key":"808_CR29","doi-asserted-by":"publisher","first-page":"5957","DOI":"10.2147\/CMAR.S313775","volume":"13","author":"XN Cen","year":"2021","unstructured":"Cen XN, Huang YM, Lu ZN, Shao WJ, Zhuo CY, Bao CC, et al. LncRNA IGFL2-AS1 promotes the proliferation, migration, and invasion of colon cancer cells and is associated with patient prognosis. Cancer Manag Res. 2021;13:5957\u201368.","journal-title":"Cancer Manag Res"},{"key":"808_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.626187","volume":"11","author":"S Bispo","year":"2021","unstructured":"Bispo S, Farias TDJ, de Araujo-Souza PS, Cintra R, Dos Santos HG, Jorge NAN, et al. Dysregulation of transcription factor networks unveils different pathways in human papillomavirus 16-positive squamous cell carcinoma and adenocarcinoma of the uterine cervix. Front Oncol. 2021;11:626187.","journal-title":"Front Oncol"},{"issue":"7","key":"808_CR31","doi-asserted-by":"publisher","first-page":"8415","DOI":"10.1002\/cam4.5562","volume":"12","author":"M Qin","year":"2023","unstructured":"Qin M, Liu Q, Yang W, Wang Q, Xiang Z. IGFL2-AS1-induced suppression of HIF-1alpha degradation promotes cell proliferation and invasion in colorectal cancer by upregulating CA9. Cancer Med. 2023;12(7):8415\u201332.","journal-title":"Cancer Med"},{"issue":"5","key":"808_CR32","first-page":"497","volume":"34","author":"S Liu","year":"2023","unstructured":"Liu S, Wang XJ, Zhang J, Liu YB, Li BH. LncRNA IGFL2-AS1 as a cerna promotes HCT116 cell malignant proliferation via the miR-433-3p\/PAK4 axis. Turk J Gastroenterol. 2023;34(5):497\u2013507.","journal-title":"Turk J Gastroenterol"},{"issue":"2","key":"808_CR33","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/odi.13935","volume":"29","author":"RM Zhao","year":"2023","unstructured":"Zhao RM, Wang SY, Tan L, Li HJ, Liu JS, Zhang SQ. IGFL2-AS1 facilitates tongue squamous cell carcinoma progression via Wnt\/beta-catenin signaling pathway. Oral Dis. 2023;29(2):469\u201382.","journal-title":"Oral Dis"},{"issue":"3","key":"808_CR34","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/mc.23155","volume":"59","author":"Y Ma","year":"2020","unstructured":"Ma Y, Liu Y, Pu YS, Cui ML, Mao ZJ, Li ZZ, et al. LncRNA IGFL2-AS1 functions as a cerna in regulating ARPP19 through competitive binding to miR-802 in gastric cancer. Mol Carcinog. 2020;59(3):311\u201322.","journal-title":"Mol Carcinog"},{"key":"808_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.canlet.2021.04.016","volume":"515","author":"H Wang","year":"2021","unstructured":"Wang H, Shi Y, Chen CH, Wen Y, Zhou Z, Yang C, et al. KLF5-induced lncRNA IGFL2-AS1 promotes basal-like breast cancer cell growth and survival by upregulating the expression of IGFL1. Cancer Lett. 2021;515:49\u201362.","journal-title":"Cancer Lett"},{"issue":"2","key":"808_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24020978","volume":"24","author":"J Lee","year":"2023","unstructured":"Lee J, Kim DY, Kim Y, Shin US, Kim KS, Kim EJ. IGFL2-AS1, a long non-coding RNA, is associated with radioresistance in colorectal cancer. Int J Mol Sci. 2023;24(2):978.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"808_CR37","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41420-023-01423-z","volume":"9","author":"B Cheng","year":"2023","unstructured":"Cheng B, Xie MY, Zhou Y, Li T, Liu WT, Yu WJ, et al. Vascular mimicry induced by m(6)A mediated IGFL2-AS1\/AR axis contributes to pazopanib resistance in clear cell renal cell carcinoma. Cell Death Discov. 2023;9(1):121.","journal-title":"Cell Death Discov"},{"issue":"1","key":"808_CR38","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1158\/0008-5472.CAN-21-3432","volume":"83","author":"YH Pan","year":"2023","unstructured":"Pan YH, Lu XX, Shu GN, Cen JJ, Lu J, Zhou M, et al. Extracellular vesicle-mediated transfer of LncRNA IGFL2-AS1 confers sunitinib resistance in renal cell carcinoma. Cancer Res. 2023;83(1):103\u201316.","journal-title":"Cancer Res"},{"issue":"3","key":"808_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111127","volume":"40","author":"XX Lu","year":"2022","unstructured":"Lu XX, Xu QL, Tong YN, Zhang ZJ, Dun GD, Feng YY, et al. Long non-coding RNA EVADR induced by Fusobacterium nucleatum infection promotes colorectal cancer metastasis. Cell Rep. 2022;40(3):111127.","journal-title":"Cell Rep"},{"issue":"1","key":"808_CR40","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s13046-022-02452-9","volume":"41","author":"Y Wang","year":"2022","unstructured":"Wang Y, Feng YC, Gan Y, Teng L, Wang L, La T, et al. LncRNA MILIP links YBX1 to translational activation of Snai1 and promotes metastasis in clear cell renal cell carcinoma. J Exp Clin Cancer Res. 2022;41(1):260.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"808_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01780-4","volume":"22","author":"YQ Wang","year":"2023","unstructured":"Wang YQ, Wei JY, Feng LY, Li OW, Huang L, Zhou SX, et al. Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2\/YBX1\/QSOX1 axis in EGFR-mutant non-small-cell lung cancer. Mol Cancer. 2023;22(1):81.","journal-title":"Mol Cancer"},{"issue":"9","key":"808_CR42","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.7150\/ijbs.78588","volume":"19","author":"ML Lu","year":"2023","unstructured":"Lu ML, Zeng YY, Yu ZQ, Chen SZ, Xie JJ, Rao BQ, et al. EIF4a3-regulated circRABL2B regulates cell stemness and drug sensitivity of lung cancer via YBX1-dependent downregulation of MUC5AC expression. Int J Biol Sci. 2023;19(9):2725\u201339.","journal-title":"Int J Biol Sci"},{"issue":"3","key":"808_CR43","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/s41556-022-00857-4","volume":"24","author":"JD Lv","year":"2022","unstructured":"Lv JD, Liu YY, Mo SQ, Zhou YB, Chen FY, Cheng FR, et al. Gasdermin E mediates resistance of pancreatic adenocarcinoma to enzymatic digestion through a YBX1-mucin pathway. Nat Cell Biol. 2022;24(3):364\u201372.","journal-title":"Nat Cell Biol"},{"key":"808_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.702491","volume":"11","author":"Q Xie","year":"2021","unstructured":"Xie Q, Zhao S, Liu W, Cui Y, Li F, Li Z, et al. YBX1 enhances metastasis and stemness by transcriptionally regulating MUC1 in lung adenocarcinoma. Front Oncol. 2021;11:702491.","journal-title":"Front Oncol"},{"key":"808_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2021.110049","volume":"85","author":"H Su","year":"2021","unstructured":"Su H, Fan G, Huang J, Qiu X. YBX1 regulated by Runx3-miR-148a-3p axis facilitates non-small-cell lung cancer progression. Cell Signal. 2021;85:110049.","journal-title":"Cell Signal"},{"issue":"4","key":"808_CR46","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41419-022-04723-x","volume":"13","author":"HB Su","year":"2022","unstructured":"Su HB, Fan GZ, Huang J, Qiu XS. LncRNA HOXC-AS3 promotes non-small-cell lung cancer growth and metastasis through upregulation of YBX1. Cell Death Dis. 2022;13(4):307.","journal-title":"Cell Death Dis"},{"issue":"1","key":"808_CR47","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.canlet.2016.01.056","volume":"374","author":"S Kumar","year":"2016","unstructured":"Kumar S, Stokes J 3rd, Singh UP, Scissum Gunn K, Acharya A, Manne U, et al. Targeting Hsp70: A possible therapy for cancer. Cancer Lett. 2016;374(1):156\u201366.","journal-title":"Cancer Lett"},{"key":"808_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/6184162","volume":"2018","author":"TL Tang","year":"2018","unstructured":"Tang TL, Yang C, Brown HE, Huang J. Circulating heat shock protein 70 is a novel biomarker for early diagnosis of lung cancer. Dis Markers. 2018;2018:1\u20138.","journal-title":"Dis Markers"},{"issue":"10","key":"808_CR49","doi-asserted-by":"publisher","DOI":"10.1093\/nsr\/nwab014","volume":"8","author":"X Wang","year":"2021","unstructured":"Wang X, Wang YT, Fang ZY, Wang H, Zhang J, Zhang LF, et al. Targeting HSPA1A in ARID2-deficient lung adenocarcinoma. Natl Sci Rev. 2021;8(10):nwab014.","journal-title":"Natl Sci Rev"},{"key":"808_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153821","volume":"94","author":"J Kan","year":"2022","unstructured":"Kan J, Fu BQ, Zhou RS, Zhou DH, Huang YF, Zhao HW, et al. He-chan pian inhibits the metastasis of non-small cell lung cancer via the miR-205-5p-mediated regulation of the GREM1\/Rap1 signaling pathway. Phytomedicine. 2022;94:153821.","journal-title":"Phytomedicine"},{"issue":"5","key":"808_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.210","volume":"8","author":"L Xiao","year":"2017","unstructured":"Xiao L, Lan XY, Shi XP, Zhao K, Wang DR, Wang XJ, et al. Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer. Cell Death Dis. 2017;8(5):e2803-e.","journal-title":"Cell Death Dis"},{"issue":"1","key":"808_CR52","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/s12935-024-03612-x","volume":"24","author":"M Nazari","year":"2024","unstructured":"Nazari M, Babakhanzadeh E, Mollazadeh A, Ahmadzade M, Mohammadi Soleimani E, Hajimaqsoudi E. HOTAIR in cancer: diagnostic, prognostic, and therapeutic perspectives. Cancer Cell Int. 2024;24(1):415.","journal-title":"Cancer Cell Int"},{"issue":"2","key":"808_CR53","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.ncrna.2024.01.015","volume":"9","author":"DX Xu","year":"2024","unstructured":"Xu DX, Wang WH, Wang D, Ding J, Zhou YN, Zhang WB. Long noncoding RNA MALAT-1: a versatile regulator in cancer progression, metastasis, immunity, and therapeutic resistance. Non-coding RNA Res. 2024;9(2):388\u2013406.","journal-title":"Non-coding RNA Res"},{"issue":"24","key":"808_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14246032","volume":"14","author":"L Zhang","year":"2022","unstructured":"Zhang L, Zhao FQ, Li WF, Song GB, Kasim V, Wu SR. The biological roles and molecular mechanisms of long non-coding RNA MEG3 in the hallmarks of cancer. Cancers (Basel). 2022;14(24):6032.","journal-title":"Cancers (Basel)"}],"container-title":["Cellular &amp; Molecular Biology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-025-00808-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11658-025-00808-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-025-00808-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:04:30Z","timestamp":1762527870000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmbl.biomedcentral.com\/articles\/10.1186\/s11658-025-00808-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["808"],"URL":"https:\/\/doi.org\/10.1186\/s11658-025-00808-5","relation":{},"ISSN":["1689-1392"],"issn-type":[{"value":"1689-1392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"8 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The procedures for animal care and use have been approved by the Animal Experimental Research Ethics Committee of Binzhou Medical University Hospital on 14 October 2022 (approval no. 20221014-101). Animal care and procedures comply with the ethical guidelines issued by the Ethics and Animal Welfare Committee of the International Scientific Committee on Experimental Animals (ICLAS) on 6\/6\/2013.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"133"}}